-
ICD-10-CM Codes
›
-
E00-E89
Endocrine, nutritional and metabolic diseases
›
-
E70-E88
Metabolic disorders
›
-
E70-
Disorders of aromatic amino-acid metabolism
›
-
2021 ICD-10-CM Diagnosis Code E70.321
2021 ICD-10-CM Diagnosis Code E70.321
Tyrosinase positive oculocutaneous albinism
2016 2017 2018 2019 2020 2021 Billable/Specific Code
- E70.321 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2021 edition of ICD-10-CM E70.321 became effective on October 1, 2020.
- This is the American ICD-10-CM version of E70.321 - other international versions of ICD-10 E70.321 may differ.
Applicable To- Albinism II
- Oculocutaneous albinism ty-pos
The following code(s) above
E70.321 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
E70.321:
- E00-E89
2021 ICD-10-CM Range E00-E89
Endocrine, nutritional and metabolic diseasesNote- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Type 1 Excludes- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
- E70-E88
2021 ICD-10-CM Range E70-E88
Metabolic disordersType 1 Excludes- androgen insensitivity syndrome (E34.5-)
- congenital adrenal hyperplasia (E25.0)
- Ehlers-Danlos syndromes (Q79.6-)
- hemolytic anemias attributable to enzyme disorders (D55.-)
- Marfan's syndrome (Q87.4)
- 5-alpha-reductase deficiency (E29.1)
- E70.32
ICD-10-CM Diagnosis Code E70.32
Oculocutaneous albinism
2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
- 642 Inborn and other disorders of metabolism
Convert E70.321 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- Albinism, albino E70.30
ICD-10-CM Diagnosis Code E70.30
Albinism, unspecified
2016 2017 2018 2019 2020 2021 Billable/Specific Code
- oculocutaneous E70.329
ICD-10-CM Diagnosis Code E70.329
Oculocutaneous albinism, unspecified
2016 2017 2018 2019 2020 2021 Billable/Specific Code
- II E70.321
ICD-10-CM Codes Adjacent To E70.321
E70.29 Other disorders of tyrosine metabolism
E70.311 Autosomal recessive ocular albinism
E70.32 Oculocutaneous albinism
E70.320 Tyrosinase negative oculocutaneous albinism
E70.321
Tyrosinase positive oculocutaneous albinism
E70.328 Other oculocutaneous albinism
E70.33 Albinism with hematologic abnormality
E70.338 Other albinism with hematologic abnormality
E70.39 Other specified albinism
E70.4 Disorders of histidine metabolism
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
